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. 3 The utilization of LD and PL DD grafts is associated with significantly decreased waiting time as well as reduced pre-transplant mortality. [4] [5] [6] Despite the use of these techniques, the waiting list mortality rate especially for the youngest pediatric patients remains several times higher than the adult waiting list mortality. 1 The optimal type of grafts is still controversial. Good outcomes have been reported after PL DD grafts, 7 but on the other hand, some studies report higher risks of graft loss when compared with whole organ deceased donors or living donors. 3, 8, 9 However, significant progress has been made since all of these techniques were introduced.
We hypothesized that, given the stagnant nature of the pediatric wait-list in terms of wait-list deaths and the lack of growth in numbers of pediatric transplants performed despite the success of split DD grafts, the use of LD in pediatric LT will lead to improved outcomes when compared to LT using DD, through appropriate preparation of the recipient particularly regarding the nutritional status, better graft quality, shorter ischemic time, and better immunologic compatibility.
| MATERIAL AND ME THODS
We conducted a retrospective cohort analysis of pediatric (<18 years old) US patients that underwent primary LT between The interpretation and reporting of these data are the responsibility of the authors and in no way should be seen as an official policy of or interpretation by the OPTN or the US Government. The University of Washington Human Subjects Division deems the OPTN database is de-identified and publicly available and thus not human subjects' data. Therefore, this study was exempt from human subject review. 
| Statistical analysis

| RE SULTS
During the study period, 6312 children received a primary LT from a LD (n = 800) or a DD (total n = 5517; PL n = 1784; WL n = 3733).
The distribution of liver transplants by age group and donor source is shown in Table 1 . Most of the LD and partial grafts occurred in children ≤2 year old. Whole liver grafts are the most common type of grafts used in all ages, although its rate increases with recipient age. Recipient and donor demographics are depicted in Table 2 . LD recipients were more likely to be white, to have cholestatic liver disease, higher lab PELD score, to receive an ABO compatible donor, to be inpatient at the time of transplant. Donors in the LD group were more likely to be older and female than DD. DD recipients (both WL and PL) were more likely to be black, to have a primary liver malignancy, to be on HD within the week of transplant, to receive an ABO identical or incompatible graft and had longer cold ischemia times.
Causes of graft lost in the 3 groups are shown in Table 3 .
TA B L E 1 Liver transplants by age group (years)
Graft type ≤2 >2-≤12
>12-18
Whole DD The overall patient and graft survival was significantly better on the LD recipients than DD (both WL and PL; Figure 1 ). When we grouped survival by age group, LD recipients ≤2 years had a signifi- Living donor liver transplant recipients showed improved patient and graft survival compared with DD (both WL and PL); this benefit of LD is higher for graft than patient survival. These findings suggest an increase rate of re-transplantation in recipients of DD (both WL and PL). These outcomes echo previous studies that showed a survival benefit of LD vs DD. Any consideration of LDLT must take into account the risks to the donor, with 40% of donors experiencing some sort of complication in the A2ALL study. 13, 14 Although most complications were minor and resolved with time, there were also reported deaths. 15 Just as center experience has been shown to be important for LDLT recipients, 16 it is likely also important for donor safety. It should be noticed, however, that the A2ALL consortium only included adult to adult living donors and most of the graft used in the pediatric population include a left lateral segment or left lobectomy with the corresponding decreased morbidity and mortality for the donor.
| D ISCUSS I ON
We recognize the potential limitation of this study inherent to a retrospective study design that uses a large national database, including the unavailability of data that may influence the choice of graft and confounders that were not controlled in our analysis.
However, the large sample size provides enough power to detect meaningful information that otherwise might have been missed in single-center studies. In conclusion, LD grafts offer a significant benefit for both patient and graft survival which is more significant in children ≤12 years. Combined with the advantages of early transplantation and decreased wait-list mortality, LD should always be considered as a first choice graft. The intention of this study is not to discourage the utilization of PL DD, but to reinforce that LD should be introduced early on in the conversation with families of children being listed for liver transplantation. Given the challenge of securing more DD for children, growing the LD numbers may be the best chance of expanding the donor pool for the pediatric population. 
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